Unlocking the Mystery of Migraine Pathogenesis
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
Key Questions
- What do pathogenesis and pathophysiology mean, specifically for migraine?
- What is the concept of a migraine pathway?
- Could understanding your migraine pathway help with specialized treatment?
- What is the trigeminal pathway?
- What role does serotonin play in migraine?
- What role does dopamine play in migraine?
- What is the GABA pathway?
- What is the vascular pathway?
- Does vasodilation cause migraine?
- What is the anti-inflammatory pathway?
- Is migraine a neuroinflammatory disorder?
- Do migraines evolve over time in patients?
- How does understanding migraine pathways lead to better understanding of migraine?
- How does better understanding of migraine help patients and treatments?
Interview Notes
Peter Goadsby, MD, PhD, FRS
Professor of Neurology and Neurologist
King's College London
Dr. Peter J. Goadsby is one of the world’s leading headache neurologists and researchers. He is a professor at King’s College London and an emeritus professor at the University of California, Los Angeles (UCLA). Dr. Goadsby is on the board of directors of the American Headache Society, and is also a trustee for The Migraine Trust.
He serves on the scientific advisory board and executive committee for the American Registry for Migraine Research (ARMR). He was one of the first to explore calcitonin gene-related peptide (CGRP), the protein known for its involvement in migraine. This discovery has been instrumental in creating the new class of medications CGRP blockers, including Aimovig (erenumab), Ajovy (fremanezumab), Emgality (galcanezumab), Nurtec ODT (rimegepant), Qulipta (atogepant), and Vyepti (eptinezumab).
Purchase full access to the entire 2024 Summit to unlock:
- All expert interviews with separate audio (MP3) files & transcripts
- 30 extended, uncut interview editions with hours more expert footage
- Lifetime on-demand access with no annual fee to 2024 Summit
- Interview Summaries
- Treatment Directory & Guidelines
- And much more!
Related Talks for: Day 1 (2021)
Why Doesn’t Migraine Have a Cure Yet?
Tissa Wijeratne, MD, FRACP, FAAN
Latest Strategies for Chronic Migraine Control
Carrie Dougherty, MD, FAHS
Finding Resilience With Migraine, Its Comorbidities, and COVID
Noah Rosen, MD, FAHS
The Coalition For Headache And Migraine Patients (CHAMP) is an organization that provides support to people with headache, migraine and cluster diseases who are often stigmatized and under-served.
CHAMP brings together organizations and leaders in this disease area to enhance communication, coordination and collaboration to more effectively help people wherever they are on their patient journey.
CHAMP is working to identify unmet needs of those with headache, migraine and cluster diseases, and will work to better support patients and their caregivers.
Eli Lilly and Company is proud to sponsor the Migraine World Summit.
Listen in as world-leading migraine and headache experts share their gratitude for the 60+ patient advocates who help produce the Summit each year.
